BNF:

Not listed

Status:

Red

Decision Date:

February 2014

Comments

RED:^1,2,5 NICE TA303: Recommended for treating adults with active relapsing remitting multiple sclerosis meeting NICE criteria

NHS England drug. To be used in line with NHS England commissioning intentions

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 5: Is new to clinical practice and unfamiliar, necessitating a period of accumulation of experience, firstly (and most rapidly) by consultants/specialists

search again